Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping

Overview

Every-two-week applied cupping (with scarification) session within one month on back of upper thorax is not compared previously regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on cardio-metabolic risk factors in fatty liver.

Full Title of Study: “Non-alcoholic Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping-with-scarification”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: December 1, 2021

Detailed Description

In fatty liver patients,every-two-week applied cupping (with scarification) session within one month on back of upper thorax for 30 patients will be compared regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) of other 30 patients.

Interventions

  • Device: laser stimulation for acupoints
    • In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9,12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian
  • Other: cupping with scarification
    • In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax

Arms, Groups and Cohorts

  • Experimental: laser
    • In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9.12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian
  • Experimental: cupping with scarification
    • In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax

Clinical Trial Outcome Measures

Primary Measures

  • high-density lipoprotein
    • Time Frame: It will be measured after 4 weeks of treatment
    • serum lipid
  • low-density lipoprotein
    • Time Frame: It will be measured after 4 weeks of treatment
    • serum lipid
  • cholesterol
    • Time Frame: It will be measured after 4 weeks of treatment
    • serum lipid
  • triglyceride
    • Time Frame: It will be measured after 4 weeks of treatment
    • serum lipid

Secondary Measures

  • c reactive protein
    • Time Frame: It will be measured after 4 weeks of treatment
    • it will be measured in plasma
  • blood glucose
    • Time Frame: It will be measured after 4 weeks of treatment
    • fasting gluocse
  • blood pressure
    • Time Frame: It will be measured after 4 weeks of treatment
    • it will be measure with manual manometer
  • rate of pulse
    • Time Frame: It will be measured after 4 weeks of treatment
    • it will be measured at radial artery

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosed Fatty liver patients by ultrasonography – Class I obese patients Exclusion Criteria:

  • Cardiovascular and respiratory disorders/diseases. – Autoimmune disorders/diseases. – Pregnancy – Other liver disorders/diseases.

Gender Eligibility: All

self-representation of gender identity.

Minimum Age: 35 Years

Maximum Age: 55 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Cairo University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ali Mohamed Ali ismail, lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University – Cairo University
  • Overall Official(s)
    • Ali Ismail, lecturer, Principal Investigator, Cairo University
  • Overall Contact(s)
    • Ali Ismail, lecturer, 02 01005154209, allooka2012@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.